Citigroup Inc. set a €130.00 ($152.94) price objective on Bayer AG (FRA:BAYN) in a research report sent to investors on Thursday. The brokerage currently has a buy rating on the healthcare company’s stock.
A number of other equities research analysts have also commented on the stock. Warburg Research set a €121.00 ($142.35) price target on shares of Bayer AG and gave the company a neutral rating in a report on Thursday. Independent Research GmbH set a €120.00 ($141.18) price objective on shares of Bayer AG and gave the stock a neutral rating in a report on Wednesday, October 4th. Baader Bank set a €140.00 ($164.71) price objective on shares of Bayer AG and gave the stock a buy rating in a report on Thursday, September 28th. BNP Paribas set a €130.00 ($152.94) price objective on shares of Bayer AG and gave the stock a buy rating in a report on Monday, September 25th. Finally, Jefferies Group LLC set a €132.00 ($155.29) price objective on shares of Bayer AG and gave the stock a buy rating in a report on Monday, September 18th. Eight equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of €121.55 ($142.99).
Bayer AG (BAYN) opened at 116.85 on Thursday. Bayer AG has a 52 week low of €85.72 and a 52 week high of €123.82. The company has a market cap of €101.91 billion and a P/E ratio of 20.21. The company’s 50-day moving average is €110.38 and its 200-day moving average is €111.88.
ILLEGAL ACTIVITY WARNING: This report was first reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://transcriptdaily.com/2017/10/09/bayer-ag-bayn-pt-set-at-130-00-by-citigroup-inc.html.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.